Skip to main content
. 2023 Aug 1;15(8):2068. doi: 10.3390/pharmaceutics15082068

Table 2.

Physicochemical characterization of mRNA LNPs in application buffer (10 mM glycylglycine, pH 5.7). Data presented as mean ± S.D., n = 3.

Formulation Composition Diameter (nm) PDI Zeta
Potential (mV)
Inaccessible mRNA (%)
LNP 1 DODMA/DOPE/PEG 201 ± 15 0.202 ± 0.043 27 ± 7 95 ± 3
LNP 2 DODMA/DOPE/pSar 239 ± 21 0.173 ± 0.028 34 ± 6 91 ± 4
LNP 3 DODMA/DOPC/PEG 221 ± 15 0.205 ± 0.021 28 ± 5 92 ± 4
LNP 4 DODMA/DOPC/pSar 242 ± 33 0.193 ± 0.040 35 ± 3 90 ± 4
LNP 5 MC3/DOPE/PEG 174 ± 07 0.124 ± 0.021 30 ± 3 96 ± 2
LNP 6 MC3/DOPE/pSar 196 ±13 0.170 ± 0.015 33 ± 2 93 ± 2
LNP 7 MC3/DOPC/PEG 159 ± 15 0.117 ±.0.024 27 ± 6 97 ± 1
LNP 8 MC3/DOPC/pSar 197 ± 17 0.156 ± 0.028 34 ± 1 94 ± 2